These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1718457)

  • 1. The main immunogenic region of the acetylcholine receptor. Structure and role in myasthenia gravis.
    Tzartos SJ; Barkas T; Cung MT; Kordossi A; Loutrari H; Marraud M; Papadouli I; Sakarellos C; Sophianos D; Tsikaris V
    Autoimmunity; 1991; 8(4):259-70. PubMed ID: 1718457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor.
    Tzartos SJ; Barkas T; Cung MT; Mamalaki A; Marraud M; Orlewski P; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P; Tsikaris V
    Immunol Rev; 1998 Jun; 163():89-120. PubMed ID: 9700504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
    Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
    J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
    Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
    Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
    Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
    Sophianos D; Tzartos SJ
    J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies.
    Fostieri E; Tzartos SJ; Berrih-Aknin S; Beeson D; Mamalaki A
    Eur J Immunol; 2005 Feb; 35(2):632-43. PubMed ID: 15627975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor.
    Tzartos S; Hochschwender S; Vasquez P; Lindstrom J
    J Neuroimmunol; 1987 Jun; 15(2):185-94. PubMed ID: 3495549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conformation of the main immunogenic region on the alpha-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits.
    Fostieri E; Beeson D; Tzartos SJ
    FEBS Lett; 2000 Sep; 481(2):127-30. PubMed ID: 10996310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; van Breda Vriesman PJ; Burton DR
    Immunol Lett; 1997 Jun; 57(1-3):59-62. PubMed ID: 9232426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.
    Luo J; Taylor P; Losen M; de Baets MH; Shelton GD; Lindstrom J
    J Neurosci; 2009 Nov; 29(44):13898-908. PubMed ID: 19890000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides.
    Tzartos SJ; Loutrari HV; Tang F; Kokla A; Walgrave SL; Milius RP; Conti-Tronconi BM
    J Neurochem; 1990 Jan; 54(1):51-61. PubMed ID: 1688377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution epitope mapping and fine antigenic characterization of the main immunogenic region of the acetylcholine receptor. Improving the binding activity of synthetic analogues of the region.
    Papadouli I; Sakarellos C; Tzartos SJ
    Eur J Biochem; 1993 Jan; 211(1-2):227-34. PubMed ID: 7678806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor.
    Tsantili P; Tzartos SJ; Mamalaki A
    J Neuroimmunol; 1999 Feb; 94(1-2):15-27. PubMed ID: 10376932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.